Overall, despite the mentioned differences in annotation and quantification (see Supplemental Table S6), we were still able to confirm the prognostic value for 466 genes out of the 1046 reported by Chen et al. (2018), including KLHDC7B-DT (also known as enhancer 22), which was highlighted as a promising prognostic marker for kidney cancer (Supplemental Fig. S5). This evidence concerns the gene KLHDC7B and kidney cancer.